Author: Jim Potter

CHC_FDA-Regulatory Images2

06/26/2018

Guest Commentary: Exploring a New Frontier in Healthcare

CHC_FDA-Regulatory Images1

06/14/2018

FDA Final Guidance Documents on Communication Issues Improve Clarity

CHC_Legislative1

06/13/2018

Azar Says FDA Has Authority to Require List Prices in Drug Ads

06/11/2018

Data Privacy and Healthcare Communications Are at a Crossroads, Ingis Says

CHC_Legislative1

06/08/2018

McCaskill Strikes Again with Transparency Bill To Expand Sunshine Provisions

News-Dick O'Brien

06/04/2018

4As’ O’Brien: Is Trump Good for the Advertising Business?

CHC_general2

05/29/2018

Rawson Shares Short- and Long-term Drug Pricing Fallout at CHC Meeting

CHC_DTCadvertisement2

05/21/2018

Debate over Listing Drug Prices in Ads Continues

kamp-john

05/16/2018

Kamp Commentary: Disclosure of Drug Prices in Ads Not a Done Deal